Insulin’s risks as second-line medicine to treat type 2 diabetes (Science daily) Adults with type 2 diabetes who take insulin in addition to the recommended first-line drug therapy, metformin, had a 30 percent higher risk of heart attack, stroke or death when compared to similar patients who instead augment their metformin regimen with a sulfonylurea, […]
